| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
| | IP | CI | | Tenoretic mite | 28 Tablet(s) | 4.85 | 14.50 | 10 % | | Coated tablets: 2 Active Agents | Atnahs Pharma Switzerland AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Tenoretic mite | 98 Tablet(s) | 14.15 | 31.75 | 10 % | | Coated tablets: 2 Active Agents | Atnahs Pharma Switzerland AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Tenoretic - T | 14 Tablet(s) | 4.53 | 14.05 | 10 % | | Coated tablets: 2 Active Agents | Atnahs Pharma Switzerland AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Tenoretic - T | 98 Tablet(s) | 28.69 | 47.45 | 10 % | | Coated tablets: 2 Active Agents | Atnahs Pharma Switzerland AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Atedurex mite | 30 Tablet(s) | 4.67 | 14.30 | 10 % | | Coated tablets: 2 Active Agents | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Atedurex mite | 100 Tablet(s) | 13.40 | 30.95 | 10 % | | Coated tablets: 2 Active Agents | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Atedurex | 10 Tablet(s) | 2.91 | 12.40 | 10 % | | Coated tablets: 2 Active Agents | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Atedurex | 100 Tablet(s) | 26.35 | 45.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Cotenolol-Mepha-Neo mite | 30 Tablet(s) | 4.44 | 14.05 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Cotenolol-Mepha-Neo mite | 100 Tablet(s) | 12.53 | 30.05 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Cotenolol-Mepha-Neo | 20 Tablet(s) | 5.50 | 15.20 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Cotenolol-Mepha-Neo | 100 Tablet(s) | 25.31 | 43.95 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | | | | Co-Atenolol-Cophar mite | 28 Coated tablet(s) | 9.20 | 21.05 | k.A. | | Coated tablets: 2 Active Agents | Cophar SA | B / SO | FB | | G |  |
| | | | | Co-Atenolol-Cophar mite | 98 Coated tablet(s) | 29.71 | 51.35 | k.A. | | Coated tablets: 2 Active Agents | Cophar SA | B / SO | FB | | G |  |
| | | | | Co-Atenolol-Cophar | 14 Coated tablet(s) | 8.57 | 18.30 | k.A. | | Coated tablets: 2 Active Agents | Cophar SA | B / SO | FB | | G |  |
| | | | | Co-Atenolol-Cophar | 98 Coated tablet(s) | 55.68 | 81.95 | k.A. | | Coated tablets: 2 Active Agents | Cophar SA | B / SO | FB | | G |  |
| | IP | CI | | Cotesifar mite | 28 Coated tablet(s) | 10.36 | 22.45 | k.A. | | Coated tablets: 2 Active Agents | Siphar SA | B / SO | FB | | G |  |
| | IP | CI | | Cotesifar mite | 98 Coated tablet(s) | 33.01 | 55.25 | k.A. | | Coated tablets: 2 Active Agents | Siphar SA | B / SO | FB | | G |  |
| | IP | CI | | Cotesifar | 14 Coated tablet(s) | 9.75 | 21.70 | k.A. | | Coated tablets: 2 Active Agents | Siphar SA | B / SO | FB | | G |  |
| | IP | CI | | Cotesifar | 98 Coated tablet(s) | 61.30 | 88.55 | k.A. | | Coated tablets: 2 Active Agents | Siphar SA | B / SO | FB | | G |  |
| | IP | CI | | Primatenol Plus mite | 28 Coated tablet(s) | PR | 22.70 | k.A. | | Coated tablets: 2 Active Agents | G. Streuli & Co. AG | B | FB | | G |  |
| | IP | CI | | Primatenol Plus mite | 98 Coated tablet(s) | PR | 55.85 | k.A. | | Coated tablets: 2 Active Agents | G. Streuli & Co. AG | B | FB | | G |  |
| | IP | CI | | Primatenol Plus | 14 Coated tablet(s) | PR | 21.50 | k.A. | | Coated tablets: 2 Active Agents | G. Streuli & Co. AG | B | FB | | G |  |
| | IP | CI | | Primatenol Plus | 98 Coated tablet(s) | PR | 85.20 | k.A. | | Coated tablets: 2 Active Agents | G. Streuli & Co. AG | B | FB | | G |  |